NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

NICE readiness commentary is a joke. If a company can’t submit evidence 5.5 years since data lock then its not a serious company that will deliver shareholder value.

The UK first strategy is also a joke. They are already at 27 months post MAA submission and yet it’s only 5-7% of the US potential. US would have made a decision in about an year. And the reimbursement per patient would be far higher.

This company will never attract any credible institutional investors ever. Forget about big pharma, LOL! ;)